EP4 receptor agonist, compositions and methods thereof

Details for Australian Patent Application No. 2006275270 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Colucci, John; Han, Yongxin; Farand, Julie A.

Agent Spruson & Ferguson

Pub. Number AU-A-2006275270

PCT Pub. Number WO2007/014454

Priority 60/705,124 03.08.05 US

Filing date 28 July 2006

Wipo publication date 8 February 2007

International Classifications

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/014454 Priority application(s): WO2007/014454

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006275272-Cancerous disease modifying antibodies

2006275263-EP4 receptor agonist, compositions and methods thereof